These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8842555

  • 1. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients.
    Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M.
    Clin Exp Allergy; 1996 Jul; 26(7):807-14. PubMed ID: 8842555
    [Abstract] [Full Text] [Related]

  • 2. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
    Fuentes-Beltrán A, Montes-Vizuet R, Valencia-Maqueda E, Negrete-García MC, García-Cruz Mde L, Teran LM.
    Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
    [Abstract] [Full Text] [Related]

  • 3. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.
    Kupczyk M, Kurmanowska Z, Kupryś-Lipińska I, Bocheńska-Marciniak M, Kuna P.
    Respir Med; 2010 Oct; 104(10):1404-9. PubMed ID: 20452758
    [Abstract] [Full Text] [Related]

  • 4. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C, Tognella S, Visconti M, Trevisan F, Dal Negro RW.
    Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
    [Abstract] [Full Text] [Related]

  • 5. Lack of association between aspirin-triggered 15-hydroxyeicosatetraenoic acid release and mast cell/eosinophil activation in nasal polyps from aspirin-sensitive patients.
    Lewandowska-Polak A, Jedrzejczak-Czechowicz M, Makowska JS, Jarzebska M, Jankowski A, Kowalski ML.
    J Investig Allergol Clin Immunol; 2011 Dec; 21(7):507-13. PubMed ID: 22312933
    [Abstract] [Full Text] [Related]

  • 6. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients.
    Ortolani C, Mirone C, Fontana A, Folco GC, Miadonna A, Montalbetti N, Rinaldi M, Sala A, Tedeschi A, Valente D.
    Ann Allergy; 1987 Nov; 59(5 Pt 2):106-12. PubMed ID: 3688566
    [Abstract] [Full Text] [Related]

  • 7. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients.
    Picado C, Ramis I, Rosellò J, Prat J, Bulbena O, Plaza V, Montserrat JM, Gelpí E.
    Am Rev Respir Dis; 1992 Jan; 145(1):65-9. PubMed ID: 1309968
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of nasal polyp mast cell and eosinophil activation by desloratadine.
    Kowalski ML, Lewandowska A, Wozniak J, Makowska J, Jankowski A, DuBuske L.
    Allergy; 2005 Jan; 60(1):80-5. PubMed ID: 15575935
    [Abstract] [Full Text] [Related]

  • 9. Nasal secretions in response to acetylsalicylic acid.
    Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, White MV, Wojciechowska B, Brayton P, Kaulbach H, Rozniecki J, Kaliner MA.
    J Allergy Clin Immunol; 1993 Feb; 91(2):580-98. PubMed ID: 8436774
    [Abstract] [Full Text] [Related]

  • 10. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C, Tognella S, Visconti M, Pomari C, Trevisan F, Dal Negro RW.
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
    Choi GS, Kim JH, Shin YS, Ye YM, Kim SH, Park HS.
    Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
    [Abstract] [Full Text] [Related]

  • 14. Association of stem cell factor expression in nasal polyp epithelial cells with aspirin sensitivity and asthma.
    Kowalski ML, Lewandowska-Polak A, Woźniak J, Ptasińska A, Jankowski A, Wagrowska-Danilewicz M, Danilewicz M, Pawliczak R.
    Allergy; 2005 May; 60(5):631-7. PubMed ID: 15813808
    [Abstract] [Full Text] [Related]

  • 15. Cysteinyl leukotriene receptor expression in aspirin-sensitive nasal polyposis patients.
    Ozen Z, Mumbuc S, Sari I, Baglam T, Karatas E, Kanlikama M.
    ORL J Otorhinolaryngol Relat Spec; 2007 May; 69(3):176-80. PubMed ID: 17264534
    [Abstract] [Full Text] [Related]

  • 16. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
    Kowalski ML, Borowiec M, Kurowski M, Pawliczak R.
    Allergy; 2007 Jun; 62(6):628-34. PubMed ID: 17508966
    [Abstract] [Full Text] [Related]

  • 17. Quantification of eosinophil cationic protein and eosinophils in nasal secretions of allergen-induced nasal inflammation.
    Wang DY, Clement P, Smitz J, De Waele M, Derde MP.
    Allergol Immunopathol (Madr); 1994 Jun; 22(4):179-83. PubMed ID: 7976971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma.
    Rolla G, Di Emanuele A, Dutto L, Marsico P, Nebiolo F, Corradi F, Brussino L, Bucca C.
    Allergy; 2004 Aug; 59(8):827-32. PubMed ID: 15230814
    [Abstract] [Full Text] [Related]

  • 20. Nasal response to allergen challenge in patients with immediate asthmatic reaction.
    Palczynski C, Krakowiak A, Ruta U, Krajewska B, Rudzinski J, Gielec L, Górski P.
    Allergol Immunopathol (Madr); 1996 Aug; 24(4):163-8. PubMed ID: 8939272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.